Ryan MJ, Schloter M, Berg G, Kostic T, Kinkel LL, Eversole K, et al. Development of microbiome biobanks – challenges and opportunities. Trends Microbiol. 2021;29(2):89–92. https://doi.org/10.1016/j.tim.2020.06.009.
Article
CAS
PubMed
Google Scholar
Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):1–11. Available from: http://dx.doi.org/https://doi.org/10.1186/s13073-016-0307-y
Ellis JL, Karl JP, Oliverio AM, Fu X, Soares JW, Wolfe BE, et al. Dietary vitamin K is remodeled by gut microbiota and influences community composition. Gut Microbes. 2021;13(1):1–16. https://doi.org/10.1080/19490976.2021.1887721.
Article
CAS
PubMed
Google Scholar
Bosco N, Noti M. The aging gut microbiome and its impact on host immunity. Genes Immun. 2021;22(5–6):289–303. https://doi.org/10.1038/s41435-021-00126-8.
Article
PubMed
PubMed Central
Google Scholar
Schären OP, Hapfelmeier S. Robust microbe immune recognition in the intestinal mucosa. Genes Immun. 2021;22(5–6):268–75. https://doi.org/10.1038/s41435-021-00131-x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anwar H, Iftikhar A, Muzaffar H, Almatroudi A, Allemailem KS, Navaid S, et al. Biodiversity of gut microbiota: impact of various host and environmental factors. Biomed Res Int. 2021;2021:1–9.
Article
Google Scholar
Li Y, Xia S, Jiang X, Feng C, Gong S, Ma J, et al. Gut microbiota and diarrhea: an updated review. Front Cell Infect Microbiol. 2021;11(April):1–8.
Google Scholar
Bistoletti M, Caputi V, Baranzini N, Marchesi N, Filpa V, Marsilio I, et al. Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice. PLoS ONE. 2019;14(2):1–20.
Article
Google Scholar
Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C. Glutamatergic signaling along the microbiota-gut-brain axis. Int J Mol Sci. 2019;20:6.
Article
Google Scholar
Wu J, Wang K, Wang X, Pang Y, Jiang C. The role of the gut microbiome and its metabolites in metabolic diseases. Protein Cell. 2021;12(5):360–73. https://doi.org/10.1007/s13238-020-00814-7.
Article
PubMed
Google Scholar
Salami M. Interplay of good bacteria and central nervous system: cognitive aspects and mechanistic considerations. Front Neurosci. 2021;11(15):25.
Google Scholar
Martin LJ, Adams RI, Bateman A, Bik HM, Hawks J, Hird SM, et al. Evolution of the indoor biome. Trends Ecol Evol. 2015;30(4):223–32.
Article
PubMed
Google Scholar
Egert M. Honor thy lodgers? – Structure and function of the human built environment microbiome. Tenside Surf Deterg. 2018;55(5):364–8. https://doi.org/10.3139/113.110577/html.
Article
CAS
Google Scholar
Stephens B. What have we learned about the microbiomes of indoor environments? mSystems. 2016;1(4):1–9.
Article
Google Scholar
Cardinale M, Kaiser D, Lueders T, Schnell S, Egert M. Microbiome analysis and confocal microscopy of used kitchen sponges reveal massive colonization by Acinetobacter Moraxella and Chryseobacterium species. Sci Reports. 2017;7(1):1–13.
CAS
Google Scholar
Hoisington AJ, Stearns-Yoder KA, Schuldt SJ, Beemer CJ, Maestre JP, Kinney KA, et al. Ten questions concerning the built environment and mental health. Build Environ. 2019;15(155):58–69.
Article
Google Scholar
Guha M, Channon B. Mental health in the built environment. J Ment Heal. 2020;29(6):611–3. https://doi.org/10.1080/09638237.2020.1836559.
Article
Google Scholar
Stamper CE, Hoisington AJ, Gomez OM, Halweg-Edwards AL, Smith DG, Bates KL, et al. The microbiome of the built environment and human behavior: implications for emotional health and well-being in postmodern western societies. Int Rev Neurobiol. 2016;1(131):289–323.
Article
Google Scholar
Gilbert JA. How do we make indoor environments and healthcare settings healthier? Microb Biotechnol. 2017;10(1):11–3. https://doi.org/10.1111/1751-7915.12430.
Article
PubMed
Google Scholar
Horve PF, Lloyd S, Mhuireach GA, Dietz L, Fretz M, MacCrone G, et al. Building upon current knowledge and techniques of indoor microbiology to construct the next era of theory into microorganisms, health, and the built environment. J Expo Sci Environ Epidemiol. 2019;30(2):219–35.
Article
PubMed
PubMed Central
Google Scholar
Chen Y, Zhou J, Wang L. Role and mechanism of gut microbiota in human disease. Front Cell Infect Microbiol. 2021;17(11):86.
Google Scholar
Dieterich W, Schink M, Zopf Y. Microbiota in the Gastrointestinal Tract. Med Sci. 2018;6(4):116.
CAS
Google Scholar
Belstrøm D. The salivary microbiota in health and disease. J Oral Microbiol. 2020. https://doi.org/10.1080/20002297.2020.1723975.
Article
PubMed
PubMed Central
Google Scholar
Chen W, Jiang Q, Yan G, Yang D. The oral microbiome and salivary proteins influence caries in children aged 6 to 8 years. BMC Oral Health. 2020;20(1):1–16. https://doi.org/10.1186/s12903-020-01262-9.
Article
CAS
Google Scholar
Mervish N, Hu J, Hagan L, Arora M, Frau C, Choi J, et al. Associations of the oral microbiota with obesity and menarche in inner city girls. J Child Obes. 2019;4(1):217.
Google Scholar
Balakrishnan B, Selvaraju V, Chen J, Ayine P, Yang L, Ramesh Babu J, et al. Ethnic variability associating gut and oral microbiome with obesity in children. Gut Microbes. 2021;13(1):1–15. https://doi.org/10.1080/19490976.2021.1882926.
Article
CAS
PubMed
Google Scholar
Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2020;19(1):55–71.
Article
PubMed
Google Scholar
Alshehri D, Saadah O, Mosli M, Edris S, Alhindi R, Bahieldin A. Dysbiosis of gut microbiota in inflammatory bowel disease: current therapies and potential for microbiota-modulating therapeutic approaches. Bosn J Basic Med Sci. 2021;21(3):270.
CAS
PubMed
PubMed Central
Google Scholar
Shi XR, Chen BY, Lin WZ, Li YL, Wang YL, Liu Y, et al. Microbiota in gut, oral cavity, and mitral valves are associated with rheumatic heart disease. Front Cell Infect Microbiol. 2021;9(11):121.
Google Scholar
Kato-Kogoe N, Sakaguchi S, Kamiya K, Omori M, Gu Y-H, Ito Y, et al. Characterization of salivary microbiota in patients with atherosclerotic cardiovascular disease: a case-control study. J Atheroscler Thromb. 2021;4:60608.
Google Scholar
Sun J, Tang Q, Yu S, Xie M, Xie Y, Chen G, et al. Role of the oral microbiota in cancer evolution and progression. Cancer Med. 2020;9(17):6306–21. https://doi.org/10.1002/cam4.3206.
Article
PubMed
PubMed Central
Google Scholar
Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, et al. Gut microbiota influence tumor development and Alter interactions with the human immune system. J Exp Clin Cancer Res. 2021;40(1):1–9. https://doi.org/10.1186/s13046-021-01845-6.
Article
Google Scholar
Yadav B, Prasad N, Saxena A. Gut microbiota dysbiosis and chronic kidney disease. J Ren Nutr Metab. 2020;6(3):70.
Article
Google Scholar
Al Khodor S, Shatat IF. Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol. 2017;32(6):921–31.
Article
PubMed
Google Scholar
Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A, et al. Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism. Mol Syst Biol. 2017;13(3):921. https://doi.org/10.15252/msb.20167356.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sarkar A, Kuehl MN, Alman AC, Burkhardt BR. Linking the oral microbiome and salivary cytokine abundance to circadian oscillations. Sci Rep. 2021;11(1):1–13.
Article
Google Scholar
Murugesan S, Al Ahmad SF, Singh P, Saadaoui M, Kumar M, Al KS. Profiling the Salivary microbiome of the Qatari population. J Transl Med. 2020;18(1):1–16. https://doi.org/10.1186/s12967-020-02291-2.
Article
CAS
Google Scholar
Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol. 2011;48(4):257–73. https://doi.org/10.1007/s00592-011-0333-6.
Article
PubMed
PubMed Central
Google Scholar
Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, et al. Microbial markers in colorectal cancer detection and/or prognosis. World J Gastroenterol. 2018;24(22):2327.
Article
PubMed
PubMed Central
Google Scholar
Cheng Y, Ling Z, Li L. The intestinal microbiota and colorectal cancer. Front Immunol. 2020;30(11):3100.
Google Scholar
Sánchez-Alcoholado L, Ramos-Molina B, Otero A, Laborda-Illanes A, Ordóñez R, Medina JA, et al. The role of the gut microbiome in colorectal cancer development and therapy response. Cancers. 2020;12(6):1406.
Article
PubMed Central
Google Scholar
Ocáriz-Díez M, Cruellas M, Gascón M, Lastra R, Martínez-Lostao L, Ramírez-Labrada A, et al. Microbiota and lung cancer opportunities and challenges for improving immunotherapy efficacy. Front Oncol. 2020;10:1945.
Article
Google Scholar
Sha S, Ni L, Stefil M, Dixon M, Mouraviev V. The human gastrointestinal microbiota and prostate cancer development and treatment. Investig Clin Urol. 2019;61(Suppl 1):S43-50.
Article
PubMed
PubMed Central
Google Scholar
Villéger R, Lopès A, Carrier G, Veziant J, Billard E, Barnich N, et al. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? Int J Mol Sci. 2019;20(18):4584.
Article
PubMed Central
Google Scholar
Venerito M, Vasapolli R, Rokkas T, Delchier JC, Malfertheiner P. Helicobacter pylori, gastric cancer and other gastrointestinal malignancies. Helicobacter. 2017. https://doi.org/10.1111/hel.12413.
Article
PubMed
Google Scholar
Nougayrède JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313(5788):848–51. https://doi.org/10.1126/science.1127059.
Article
CAS
PubMed
Google Scholar
Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut. 2014;63(12):1932–42.
Article
CAS
PubMed
Google Scholar
Gagnière J, Bonnin V, Jarrousse AS, Cardamone E, Agus A, Uhrhammer N, et al. Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer. Clin Sci. 2017;131(6):471–85.
Article
Google Scholar
Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE. 2013;8(2):e56964. https://doi.org/10.1371/journal.pone.0056964.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, et al. Colonization of the Human Gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014;20(4):859–67.
Article
PubMed
Google Scholar
EP3666905A1. E. coli positive for pks island as marker of positive response to anti-pd1 therapy in colorectal cancer. Google Patents. https://patents.google.com/patent/EP3666905A1/en
Karpiński TM. Role of oral microbiota in cancer development. Microorg. 2019;7(1):20.
Article
Google Scholar
Karpiński TM. The microbiota and pancreatic cancer. Gastroenterol Clin. 2019;48(3):447–64.
Article
Google Scholar
Wang PX, Deng XR, Zhang CH, Yuan HJ. Gut microbiota and metabolic syndrome. Chin Med J (Engl). 2020;133(7):808.
Article
Google Scholar
Agus A, Denizot J, Thévenot J, Martinez-Medina M, Massier S, Sauvanet P, et al. Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation. Sci Rep. 2016;6:8.
Article
Google Scholar
Tronnet S, Floch P, Lucarelli L, Gaillard D, Martin P, Serino M, et al. The genotoxin colibactin shapes gut microbiota in mice. Gut. 2020;8:9.
Google Scholar
Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:8.
Article
Google Scholar
Jazani NH, Savoj J, Lustgarten M, Lau WL, Vaziri ND. Impact of gut dysbiosis on neurohormonal pathways in chronic kidney disease. Disease. 2019;7(1):21.
Article
CAS
Google Scholar
Li Y, Su X, Zhang L, Liu Y, Shi M, Lv C, et al. Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case-controlled study. J Transl Med. 2019;17(1):1–13. https://doi.org/10.1186/s12967-019-1969-1.
Article
CAS
Google Scholar
Li FX, Wang MH, Wang JP, Li RS, Zhang YQ. Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Front Cell Infect Microbiol. 2019;9(6):206.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bryniarski MA, Hamarneh F, Yacoub R. The role of chronic kidney disease-associated dysbiosis in cardiovascular disease. Exp Biol Med. 2019;244(6):514–25. https://doi.org/10.1177/1535370219826526.
Article
CAS
Google Scholar
Durand PY, Nicco C, Serteyn D, Attaf D, Edeas M. Microbiota quality and mitochondrial activity link with occurrence of muscle cramps in hemodialysis patients using citrate dialysate: a pilot study. Blood Purif. 2018;46(4):301–8.
Article
CAS
PubMed
Google Scholar
Lakshmanan AP, Al Zaabi M, Ali BH, Terranegra A. The influence of the prebiotic gum acacia on the intestinal microbiome composition in rats with experimental chronic kidney disease. Biomed Pharmacother. 2021;133:110992.
Article
CAS
PubMed
Google Scholar
Jiang X, Zheng J, Zhang S, Wang B, Wu C, Guo X. Advances in the involvement of gut microbiota in pathophysiology of NAFLD. Front Med. 2020;7:1–16.
Article
CAS
Google Scholar
Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Spurnic AR, et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int J Mol Sci. 2019;20(2):1–16.
Article
Google Scholar
Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318(1):G84-98.
Article
CAS
PubMed
Google Scholar
Edwards SM, Cunningham SA, Dunlop AL, Corwin EJ. The Maternal Gut Microbiome during Pregnancy. MCN Am J Matern Child Nurs. 2017;42(6):310.
Article
PubMed
PubMed Central
Google Scholar
Yang H, Guo R, Li S, Liang F, Tian C, Zhao X, et al. Systematic analysis of gut microbiota in pregnant women and its correlations with individual heterogeneity. Biofilms Microbiomes. 2020;6(1):1–12.
CAS
Google Scholar
Zhang D, Huang Y, Ye D. Intestinal dysbiosis: an emerging cause of pregnancy complications? Med Hypotheses. 2015;84(3):223–6.
Article
PubMed
Google Scholar
Ma S, You Y, Huang L, Long S, Zhang J, Guo C, et al. Alterations in gut microbiota of gestational diabetes patients during the first trimester of pregnancy. Front Cell Infect Microbiol. 2020;27(10):58.
Article
Google Scholar
Zheng W, Xu Q, Huang W, Yan Q, Chen Y, Zhang L, et al. Gestational diabetes mellitus is associated with reduced dynamics of gut microbiota during the first half of pregnancy. mSystems. 2020;5:2. https://doi.org/10.1128/mSystems.00109-20.
Article
Google Scholar
Kuang YS, Lu JH, Li SH, Li JH, Yuan MY, He JR, et al. Connections between the human gut microbiome and gestational diabetes mellitus. Gigascience. 2017;6:8.
Article
Google Scholar
Deepa R, Lewis MG, Van Schayck OCP, Babu GR. Food habits in pregnancy and its association with gestational diabetes mellitus: results from a prospective cohort study in public hospitals of urban India. BMC Nutr. 2020;6(1):1–9. https://doi.org/10.1186/s40795-020-00388-x.
Article
Google Scholar
Hasain Z, Mokhtar NM, Kamaruddin NA, Mohamed Ismail NA, Razalli NH, Gnanou JV, et al. Gut microbiota and gestational diabetes mellitus: a review of host-gut microbiota interactions and their therapeutic potential. Front Cell Infect Microbiol. 2020;15(10):188.
Article
Google Scholar
Wang J, Shi Z-H, Yang J, Wei Y, Wang X-Y, Zhao Y-Y. Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters. Chin Med J Engl. 2020;133(9):1057.
Article
PubMed
PubMed Central
Google Scholar
Chen X, Li P, Liu M, Zheng H, He Y, Chen MX, et al. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut. 2020;69(3):513–22.
Article
CAS
PubMed
Google Scholar
Chouzenoux S, Jeljeli M, Bourdon M, Doridot L, Thomas M, Barbeito A, et al. A new strategy against endometriosis: Oral probiotic treatments. Clin Obstet Gynecol Reprod Med. 2021;7(1):1–11.
Google Scholar
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nat. 2018;555(7698):623–8.
Article
CAS
Google Scholar
Macedo D, Filho AJMC, Soares de Sousa CN, Quevedo J, Barichello T, Júnior HVN, et al. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. J Affect Disord. 2017;208:22–32.
Article
CAS
PubMed
Google Scholar
Liśkiewicz P, Pełka-Wysiecka J, Kaczmarczyk M, Łoniewski I, Wroński M, Baba-Kubiś A, et al. Fecal microbiota analysis in patients going through a depressive episode during treatment in a psychiatric hospital setting. J Clin Med. 2019;8(2):164.
Article
PubMed Central
Google Scholar
Liśkiewicz P, Kaczmarczyk M, Misiak B, Wroński M, Bąba-Kubiś A, Skonieczna-Żydecka K, et al. Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder. Prog Neuro-Psychopharmacology Biol Psychiatry. 2021;106:110076.
Article
Google Scholar
Łoniewski I, Misera A, Skonieczna-Żydecka K, Kaczmarczyk M, Kaźmierczak-Siedlecka K, Misiak B, et al. Major depressive disorder and gut microbiota – association not causation. A scoping review. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;106:110111.
Article
Google Scholar
Misera A, Liśkiewicz P, Łoniewski I, Skonieczna-Żydecka K, Samochowiec J. Effect of psychobiotics on psychometric tests and inflammatory markers in major depressive disorder: meta-analysis of randomized controlled trials with meta-regression. Pharm. 2021;14(10):952.
CAS
Google Scholar
Skonieczna-Żydecka K, Łoniewski I, Misera A, Stachowska E, Maciejewska D, Marlicz W, et al. Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome. Psychopharmacology. 2019;236(5):1491–512. https://doi.org/10.1007/s00213-018-5102-6.
Article
CAS
PubMed
Google Scholar
Pełka-Wysiecka J, Kaczmarczyk M, Bąba-Kubiś A, Liśkiewicz P, Wroński M, Skonieczna-żydecka K, et al. Analysis of gut microbiota and their metabolic potential in patients with schizophrenia treated with olanzapine: results from a six-week observational prospective cohort study. J Clin Med. 2019;8(10):1605.
Article
PubMed Central
Google Scholar
Krautkramer KA, Fan J, Bäckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2020;19(2):77–94.
Article
PubMed
Google Scholar
Liu Y, Hou Y, Wang G, Zheng X, Hao H. Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay. Trends Endocrinol Metab. 2020;31(11):818–34.
Article
CAS
PubMed
Google Scholar
Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019;7(1):1–15. https://doi.org/10.1186/s40168-019-0704-8.
Article
Google Scholar
Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6):1174–82.
Article
CAS
PubMed
Google Scholar
Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15(5):261–73.
Article
CAS
PubMed
Google Scholar
Herrema H, Niess JH. Intestinal microbial metabolites in human metabolism and type 2 diabetes. Diabetol. 2020;63(12):2533–47. https://doi.org/10.1007/s00125-020-05268-4.
Article
Google Scholar
Kasahara K, Rey FE. The emerging role of gut microbial metabolism on cardiovascular disease. Curr Opin Microbiol. 2019;1(50):64–70.
Article
Google Scholar
Jansen VL, Gerdes VE, Middeldorp S, van Mens TE. Gut microbiota and their metabolites in cardiovascular disease. Best Pract Res Clin Endocrinol Metab. 2021;35(3):101492.
Article
CAS
PubMed
Google Scholar
Tarashi S, Siadat SD, Badi SA, Zali M, Biassoni R, Ponzoni M, et al. Gut bacteria and their metabolites: which one is the defendant for colorectal cancer? Microorg. 2019;7(11):561.
Article
CAS
Google Scholar
Weissig V, Edeas M. Recent developments in mitochondrial medicine (Part 1). Open. 2021;4:2.
Google Scholar
Rajha HN, Paule A, Aragonès G, Barbosa M, Caddeo C, Debs E, et al. Recent advances in research on polyphenols: effects on microbiota, metabolism, and health. Mol Nutr Food Res. 2021. https://doi.org/10.1002/mnfr.202100670.
Article
PubMed
Google Scholar
Jaworska K, Bielinska K, Gawrys-Kopczynska M, Ufnal M. TMA (trimethylamine), but not its oxide TMAO (trimethylamine-oxide), exerts haemodynamic effects: implications for interpretation of cardiovascular actions of gut microbiome. Cardiovasc Res. 2019;115(14):1948–9.
Article
CAS
PubMed
Google Scholar
Jaworska K, Hering D, Mosieniak G, Bielak-Zmijewska A, Pilz M, Konwerski M, et al. TMA, A forgotten uremic toxin, but not TMAO, is involved in cardiovascular pathology. Toxins. 2019;11(9):490.
Article
CAS
PubMed Central
Google Scholar
Jaworska K, Konop M, Hutsch T, Perlejewski K, Radkowski M, Grochowska M, et al. Trimethylamine but not trimethylamine oxide increases with age in rat plasma and affects smooth muscle cells viability. J Gerontol Ser A. 2020;75(7):1276–83.
Article
CAS
Google Scholar
Tsvetikova SA, Koshel EI. Microbiota and cancer: host cellular mechanisms activated by gut microbial metabolites. Int J Med Microbiol. 2020;310(4):151425.
Article
CAS
PubMed
Google Scholar
Nakkarach A, Foo HL, Song AAL, Mutalib NEA, Nitisinprasert S, Withayagiat U. Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota. Microb Cell Fact. 2021;20(1):1–17. https://doi.org/10.1186/s12934-020-01477-z.
Article
CAS
Google Scholar
Cueva C, Silva M, Pinillos I, Bartolomé B, Moreno-Arribas MV. Interplay between dietary polyphenols and oral and gut microbiota in the development of colorectal cancer. Nutr. 2020;12(3):625.
CAS
Google Scholar
Ilhan ZE, DiBaise JK, Dautel SE, Isern NG, Kim YM, Hoyt DW, et al. Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery. Biofilms Microbiomes. 2020;6(1):1–12.
Google Scholar
Samczuk P, Luba M, Godzien J, Mastrangelo A, Hady HR, Dadan J, et al. “Gear mechanism” of bariatric interventions revealed by untargeted metabolomics. J Pharm Biomed Anal. 2018;20(151):219–26.
Article
Google Scholar
Samczuk P, Hady HR, Adamska-Patruno E, Citko A, Dadan J, Barbas C, et al. In-and-out molecular changes linked to the type 2 diabetes remission after bariatric surgery: an influence of gut microbes on mitochondria metabolism. Int J Mol Sci. 2018;19(12):3744.
Article
PubMed Central
Google Scholar
Samczuk P, Ciborowski M, Kretowski A. Application of metabolomics to study effects of bariatric surgery. J Diabetes Res. 2018;2018:90.
Article
Google Scholar
Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieërs G, Guery B, et al. The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol. 2020;19(10):9.
Article
Google Scholar
Grier A, McDavid A, Wang B, Qiu X, Java J, Bandyopadhyay S, et al. Neonatal gut and respiratory microbiota: Coordinated development through time and space. Microbiome. 2018;6(1):1–19. https://doi.org/10.1186/s40168-018-0566-5.
Article
Google Scholar
Yin GF, Li B, Fan XM. Effects and mechanism of fecal transplantation on acute lung injury induced by lipopolysaccharide in rats. Zhonghua Yi Xue Za Zhi. 2019;99(20):1582–7.
CAS
PubMed
Google Scholar
Biliński J, Winter K, Jasiński M, Szczȩś A, Bilinska N, Mullish BH, et al. Rapid resolution of COVID-19 after faecal microbiota transplantation. Gut. 2022;71(1):230–2.
Article
PubMed
Google Scholar
Antunes KH, Fachi JL, de Paula R, da Silva EF, Pral LP, dos Santos AÁ, et al. Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun. 2019;10(1):1–17.
Article
CAS
Google Scholar
Bradley KC, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, et al. Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell Rep. 2019;28(1):245-256.e4.
Article
CAS
PubMed
Google Scholar
Sencio V, Machado MG, Trottein F. The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunol. 2021;14(2):296–304.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saint-Criq V, Lugo-Villarino G, Thomas M. Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases. Ageing Res Rev. 2021;66:101235.
Article
CAS
PubMed
Google Scholar
Majewski S, Piotrowski W. Pulmonary manifestations of inflammatory bowel disease. Arch Med Sci. 2015;11(6):1179.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taveras NT, Martinez AR, Kumar R, Jamil A, Kumar B. Pulmonary manifestations of inflammatory bowel disease. Cureus. 2021;13:3.
Google Scholar
Frati F, Salvatori C, Incorvaia C, Bellucci A, Di Cara G, Marcucci F, et al. The role of the microbiome in asthma: the gut-lung axis. Int J Mol Sci. 2019;20(1):123.
Article
Google Scholar
Barcik W, Boutin RCT, Sokolowska M, Finlay BB. The role of lung and gut microbiota in the pathology of asthma. Immunity. 2020;52(2):241–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Turturice BA, McGee HS, Oliver B, Baraket M, Nguyen BT, Ascoli C, et al. Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction. PLoS ONE. 2017;12(10):e0184566. https://doi.org/10.1371/journal.pone.0184566.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hufnagl K, Pali-Schöll I, Roth-Walter F, Jensen-Jarolim E. Dysbiosis of the gut and lung microbiome has a role in asthma. Semin Immunopathol. 2020;42(1):75–93. https://doi.org/10.1007/s00281-019-00775-y.
Article
PubMed
PubMed Central
Google Scholar
Durack J, Kimes NE, Lin DL, Rauch M, McKean M, McCauley K, et al. Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation. Nat Commun. 2018;9(1):1–9.
Article
CAS
Google Scholar
Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020;11(1):1–15.
Article
Google Scholar
Mateer SW, Maltby S, Marks E, Foster PS, Horvat JC, Hansbro PM, et al. Potential mechanisms regulating pulmonary pathology in inflammatory bowel disease. J Leukoc Biol. 2015;98(5):727–37. https://doi.org/10.1189/jlb.3RU1114-563R.
Article
CAS
PubMed
Google Scholar
Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A. Increased Risk of Both Ulcerative Colitis and Crohn’s Disease in a Population Suffering from COPD. Lung. 2008;186(3):167–72. https://doi.org/10.1007/s00408-008-9080-z.
Article
PubMed
Google Scholar
Vaughan A, Frazer ZA, Hansbro PM, Yang IA. COPD and the gut-lung axis: the therapeutic potential of fibre. J Thorac Dis. 2019;11(Suppl 17):S2173.
Article
PubMed
PubMed Central
Google Scholar
Liu NN, Ma Q, Ge Y, Yi CX, Wei LQ, Tan JC, et al. Microbiome dysbiosis in lung cancer: from composition to therapy. Precis Oncol. 2020;4(1):1–12.
Google Scholar
Zhao Y, Liu Y, Li S, Peng Z, Liu X, Chen J, et al. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol. 2021;147(8):2177–86. https://doi.org/10.1007/s00432-021-03644-0.
Article
PubMed
PubMed Central
Google Scholar
de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CRB. Microbiota modulation of the gut-lung axis in COVID-19. Front Immunol. 2021;12:9.
Article
Google Scholar
Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1–7. https://doi.org/10.1016/j.mito.2020.06.008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut Microbes and the Brain: Paradigm Shift in Neuroscience. J Neurosci. 2014;34(46):15490–6.
Article
PubMed
PubMed Central
Google Scholar
Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson’s disease. World J Gastroenterol. 2015;21(37):10609.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kowalski K, Mulak A. Brain-Gut-Microbiota Axis in Alzheimer’s Disease. J Neurogastroenterol Motil. 2019;25(1):48.
Article
PubMed
PubMed Central
Google Scholar
Morais LH, Schreiber HL, Mazmanian SK. The gut microbiota–brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2020;19(4):241–55.
Article
PubMed
Google Scholar
Maiuolo J, Gliozzi M, Musolino V, Carresi C, Scarano F, Nucera S, et al. The contribution of gut microbiota-brain axis in the development of brain disorders. Front Neurosci. 2021;23(15):170.
Google Scholar
Sudo N. Role of gut microbiota in brain function and stress-related pathology. Biosci Microbiota Food Heal. 2019;38(3):19–006.
Google Scholar
Sabit H, Tombuloglu H, Rehman S, Almandil NB, Cevik E, Abdel-Ghany S, et al. Gut microbiota metabolites in autistic children: An epigenetic perspective. Heliyon. 2021;7(1):e06105.
Article
PubMed
PubMed Central
Google Scholar
Szeligowski T, Yun AL, Lennox BR, Burnet PWJ. The Gut Microbiome and Schizophrenia: the current state of the field and clinical applications. Front Psychiatry. 2020;12(11):156.
Article
Google Scholar
Schepici G, Silvestro S, Bramanti P, Mazzon E. The gut microbiota in multiple sclerosis: an overview of clinical trials. Cell Transplant. 2019;28(12):1507–27. https://doi.org/10.1177/0963689719873890.
Article
PubMed
PubMed Central
Google Scholar
Pasinetti GM, Naughton SX, Trageser KJ, Harary JM, Westfall S. Defining the Role of Gut Microbiota-Derived Ketamine Metabolites in Alzheimer’s Disease. ALZ; 2020. https://alz.confex.com/alz/20amsterdam/meetingapp.cgi/Paper/46152
Keshavarzian A, Engen P, Bonvegna S, Cilia R. The gut microbiome in Parkinson’s disease: a culprit or a bystander? Prog Brain Res. 2020;1(252):357–450.
Article
Google Scholar
Tian T, Xu B, Qin Y, Fan L, Chen J, Zheng P, et al. Clostridium butyricum miyairi 588 has preventive effects on chronic social defeat stress-induced depressive-like behaviour and modulates microglial activation in mice. Biochem Biophys Res Commun. 2019;516(2):430–6.
Article
CAS
PubMed
Google Scholar
Rutsch A, Kantsjö JB, Ronchi F. The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol. 2020;10(11):3237.
Google Scholar
Friedland RP. Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J Alzheimer’s Dis. 2015;45(2):349–62.
Article
CAS
Google Scholar
Quigley EMM. Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep. 2017;17(12):1–9. https://doi.org/10.1007/s11910-017-0802-6.
Article
CAS
Google Scholar
Westfall S, Dinh DM, Pasinetti GM. Investigation of Potential Brain Microbiome in Alzheimer’s Disease: implications of Study Bias. J Alzheimer’s Dis. 2020;75(2):559–70.
Article
CAS
Google Scholar
Shen L, Ji HF. Associations between gut microbiota and alzheimer’s disease: current evidences and future therapeutic and diagnostic perspectives. J Alzheimer’s Dis. 2019;68(1):25–31.
Article
Google Scholar
Frolinger T, Sims S, Smith C, Wang J, Cheng H, Faith J, et al. The gut microbiota composition affects dietary polyphenols-mediated cognitive resilience in mice by modulating the bioavailability of phenolic acids. Sci Rep. 2019;12:9.
Google Scholar
Abdallah F, Mijouin L, Pichon C. Skin Immune Landscape: Inside and Outside the Organism. Mediators Inflamm. 2017;2017:89.
Article
Google Scholar
Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143–55.
Article
CAS
PubMed
Google Scholar
Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. 2018;9:1–14.
Article
Google Scholar
Ellis SR, Nguyen M, Vaughn AR, Notay M, Burney WA, Sandhu S, et al. The skin and gut microbiome and its role in common dermatologic conditions. Microorg. 2019;7(11):550.
Article
CAS
Google Scholar
Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorg. 2021;9(2):353.
Article
Google Scholar
Hsu DK, Fung MA, Chen HL. Role of skin and gut microbiota in the pathogenesis of psoriasis, an inflammatory skin disease. Med Microecol. 2020;4:100016.
Article
Google Scholar
Reddel S, Del Chierico F, Quagliariello A, Giancristoforo S, Vernocchi P, Russo A, et al. Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture. Sci Rep. 2019;9(1):1–10.
Article
CAS
Google Scholar
Vergara D, Simeone P, Damato M, Maffia M, Lanuti P, Trerotola M. The Cancer Microbiota: EMT and inflammation as shared molecular mechanisms associated with plasticity and progression. J Oncol. 2019;2019:9.
Article
Google Scholar
Yerushalmi M, Elalouf O, Anderson M, Chandran V. The skin microbiome in psoriatic disease: a systematic review and critical appraisal. J Transl Autoimmun. 2019;2:100009.
Article
PubMed
PubMed Central
Google Scholar
Sikora M, Stec A, Chrabaszcz M, Knot A, Waskiel-Burnat A, Rakowska A, et al. Gut microbiome in psoriasis: an updated review. Pathog. 2020;9(6):463.
Article
CAS
Google Scholar
Herbert D, Franz S, Popkova Y, Anderegg U, Schiller J, Schwede K, et al. High-fat diet exacerbates early psoriatic skin inflammation independent of obesity: saturated fatty acids as key players. J Invest Dermatol. 2018;138(9):1999–2009.
Article
CAS
PubMed
Google Scholar
Kim M, Han KD, Lee JH. Bodyweight variability and the risk of psoriasis: a nationwide population-based cohort study. J Eur Acad Dermatology Venereol. 2020;34(5):1019–25. https://doi.org/10.1111/jdv.16099.
Article
CAS
Google Scholar
Chen L, Li J, Zhu W, Kuang Y, Liu T, Zhang W, et al. Skin and gut microbiome in psoriasis: gaining insight into the pathophysiology of it and finding novel therapeutic strategies. Front Microbiol. 2020;15(11):3201.
Google Scholar
Sikora M, Kiss N, Stec A, Giebultowicz J, Samborowska E, Jazwiec R, et al. Trimethylamine N-oxide, a gut microbiota-derived metabolite, is associated with cardiovascular risk in psoriasis: a cross-sectional pilot study. Dermatol Ther (Heidelb). 2021;11(4):1277–89. https://doi.org/10.1007/s13555-021-00547-3.
Article
PubMed
PubMed Central
Google Scholar
Sanchez IM, Jiang W, Yang EJ, Singh RK, Beck K, Liu C, et al. Enteropathy in psoriasis: a systematic review of gastrointestinal disease epidemiology and subclinical inflammatory and functional gut alterations. Curr Dermatol Rep. 2018;7(1):59–74. https://doi.org/10.1007/s13671-018-0213-1.
Article
Google Scholar
Lee YB, Byun EJ, Kim HS. Potential role of the microbiome in acne: a comprehensive review. J Clin Med. 2019;8(7):987.
Article
CAS
PubMed Central
Google Scholar
Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125(6):1401–12.
Article
CAS
PubMed
Google Scholar
Scott KP, Tuohy KM, Mach-Istituto FE, San A, Alladige M, Gibson GR, et al. Dietary prebiotics: current status and new definition. Food Sci Technol Bull Funct Foods. 2010;7(1):1–19.
Article
Google Scholar
Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8(3):92.
Article
CAS
PubMed Central
Google Scholar
Naseer M, Poola S, Ali S, Samiullah S, Tahan V. Prebiotics and probiotics in inflammatory bowel disease: where are we now and where are we going? Curr Clin Pharmacol. 2020;15(3):216–33.
CAS
PubMed
Google Scholar
Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut. 2006;55(3):348–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brochot A, Azalbert V, Landrier JF, Tourniaire F, Serino M. A Two-week treatment with plant extracts changes gut microbiota, caecum metabolome, and markers of lipid metabolism in ob/ob Mice. Mol Nutr Food Res. 2019;63(17):1–12.
Google Scholar
Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, et al. Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility. Biomed Res Int. 2013;2013:90.
Article
Google Scholar
Ambalam P, Raman M, Purama RK, Doble M. Probiotics, prebiotics and colorectal cancer prevention. Best Pract Res Clin Gastroenterol. 2016;30(1):119–31.
Article
PubMed
Google Scholar
Xie X, He Y, Li H, Yu D, Na L, Sun T, et al. Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients. Nutrition. 2019;1(61):132–42.
Article
Google Scholar
Suganya K, Koo BS. Gut-brain axis: role of gut microbiota on neurological disorders and how probiotics/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int J Mol Sci. 2020;21(20):7551.
Article
CAS
PubMed Central
Google Scholar
Kong G, Cao KAL, Judd LM, Li SS, Renoir T, Hannan AJ. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington’s disease. Neurobiol Dis. 2021;135:104268.
Article
Google Scholar
Wasser CI, Mercieca E-C, Kong G, Hannan AJ, McKeown SJ, Glikmann-Johnston Y, et al. Gut dysbiosis in Huntington’s disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun. 2020;2:2.
Article
Google Scholar
Yang H, Liu Y, Cai R, Li Y, Gu B. A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics. Ann Palliat Med. 2021;10(2):2304–13.
Article
PubMed
Google Scholar
Johnstone N, Milesi C, Burn O, van den Bogert B, Nauta A, Hart K, et al. Anxiolytic effects of a galacto-oligosaccharides prebiotic in healthy females (18–25 years) with corresponding changes in gut bacterial composition. Sci Reports. 2021;11(1):1–11.
Google Scholar
Reid G. Probiotics: definition, scope and mechanisms of action. Best Pract Res Clin Gastroenterol. 2016;30(1):17–25.
Article
CAS
PubMed
Google Scholar
Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the treatment of overweight and obesity in humans—a review of clinical trials. Microorg. 2020;8(8):1148.
Article
Google Scholar
Tiderencel KA, Hutcheon DA, Ziegler J. Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials. Diabetes Metab Res Rev. 2020;36(1):e3213. https://doi.org/10.1002/dmrr.3213.
Article
CAS
PubMed
Google Scholar
Tao YW, Gu YL, Mao XQ, Zhang L, Pei YF. Effects of probiotics on type II diabetes mellitus: A meta-analysis. J Transl Med. 2020;18(1):1–11. https://doi.org/10.1186/s12967-020-02213-2.
Article
CAS
Google Scholar
Herndon CC, Wang YP, Lu CL. Targeting the gut microbiota for the treatment of irritable bowel syndrome. Kaohsiung J Med Sci. 2020;36(3):160–70. https://doi.org/10.1002/kjm2.12154.
Article
PubMed
Google Scholar
He X, Zhao S, Li Y. Faecalibacterium prausnitzii: A Next-Generation Probiotic in Gut Disease Improvement. Can J Infect Dis Med Microbiol. 2021;2021:67.
Article
Google Scholar
Lapiere A, Geiger M, Robert V, Demarquay C, Auger S, Chadi S, et al. Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease. Gut Microbes. 2020;12(1):1–15. https://doi.org/10.1080/19490976.2020.1812867.
Article
CAS
PubMed
Google Scholar
Shahbazi R, Yasavoli-Sharahi H, Alsadi N, Ismail N, Matar C. Probiotics in treatment of viral respiratory infections and neuroinflammatory disorders. Molecule. 2020;25(21):4891.
Article
CAS
Google Scholar
Morshedi M, Hashemi R, Moazzen S, Sahebkar A, Hosseinifard ES. Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review. J Neuroinflammation. 2019;16(1):1–11. https://doi.org/10.1186/s12974-019-1611-4.
Article
CAS
Google Scholar
Arora K, Green M, Prakash S. The microbiome and alzheimer’s disease: potential and limitations of prebiotic, synbiotic, and probiotic formulations. Front Bioeng Biotechnol. 2020;14(8):1411.
Google Scholar
Caselli E, Arnoldo L, Rognoni C, D’Accolti M, Soffritti I, Lanzoni L, et al. Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multicenter study. Infect Drug Resist. 2019;12:501.
Article
CAS
PubMed
PubMed Central
Google Scholar
Caselli E, Brusaferro S, Coccagna M, Arnoldo L, Berloco F, Antonioli P, et al. Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: A multicentre, prospective, intervention study. PLoS ONE. 2018;13(7):e0199616. https://doi.org/10.1371/journal.pone.0199616.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim KO, Gluck M. Fecal microbiota transplantation: an update on clinical practice. Clin Endosc. 2019;52(2):137.
Article
PubMed
PubMed Central
Google Scholar
Napolitano M, Covasa M. Microbiota transplant in the treatment of obesity and diabetes: current and future perspectives. Front Microbiol. 2020;12(11):2877.
Google Scholar
Leshem A, Horesh N, Elinav E. Fecal microbial transplantation and its potential application in cardiometabolic syndrome. Front Immunol. 2019;10:1341.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nicco C, Paule A, Konturek P, Edeas M. From donor to patient: collection, preparation and cryopreservation of fecal samples for fecal microbiota transplantation. Dis. 2020;8(2):9.
CAS
Google Scholar
Reygner J, Charrueau C, Delannoy J, Mayeur C, Robert V, Cuinat C, et al. Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of Clostridioides difficile infection. Gut Microbes. 2020;11(5):1405–22. https://doi.org/10.1080/19490976.2020.1759489.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheminet G, Kapel N, Bleibtreu A, Sadou-Yaye H, Bellanger A, Duval X, et al. Faecal microbiota transplantation with frozen capsules for relapsing Clostridium difficile infections: the first experience from 15 consecutive patients in France. J Hosp Infect. 2018;100(2):148–51.
Article
CAS
PubMed
Google Scholar
WO2017103225A1. Lyophilized composition for preserving microbiota in its ecosystem - Google Patents. 2021. https://patents.google.com/patent/WO2017103225A1/en
Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Mauris A, Galperine T, et al. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial. Clin Microbiol Infect. 2019;25(7):830–8.
Article
CAS
PubMed
Google Scholar
Bilinski J, Grzesiowski P, Sorensen N, Madry K, Muszynski J, Robak K, et al. Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, Single-Center Study. Clin Infect Dis. 2017;65(3):364–70.
Article
CAS
PubMed
Google Scholar
Singh R, De Groot PF, Geerlings SE, Hodiamont CJ, Belzer C, Berge IJMT, et al. Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: A proof of principle study ISRCTN48328635 ISRCTN. BMC Res Notes. 2018;11(1):1–6. https://doi.org/10.1186/s13104-018-3293-x.
Article
CAS
Google Scholar
Leung V, Vincent C, Edens TJ, Miller M, Manges AR. Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation for recurrent Clostridium difficile Infection. Clin Infect Dis. 2018;66(3):456–7.
Article
CAS
PubMed
Google Scholar
Davido B, Salomon J, Lawrence C, Duran C, Batista R, De Truchis P, et al. Impact of fecal microbiota transplantation for decolonization of multidrug-resistant organisms may vary according to donor microbiota. Clin Infect Dis. 2018;66(8):1316–7.
PubMed
Google Scholar
Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, et al. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clin Microbiol Infect. 2019;25(7):807–17.
Article
CAS
PubMed
Google Scholar
Bilinski J, Robak K, Peric Z, Marchel H, Karakulska-Prystupiuk E, Halaburda K, et al. Impact of Gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem cell transplantation: a retrospective. Single-Center Study Biol Blood Marrow Transplant. 2016;22(6):1087–93.
Article
PubMed
Google Scholar
Peric Z, Vranjes VR, Durakovic N, Desnica L, Marekovic I, Serventi-Seiwerth R, et al. Gut colonization by multidrug-resistant gram-negative bacteria is an independent risk factor for development of intestinal acute graft-versus-host disease. Biol Blood Marrow Transplant. 2017;23(7):1221–2.
Article
PubMed
Google Scholar
Biliński J, Grzesiowski P, Muszyński J, Wróblewska M, Mądry K, Robak K, et al. Fecal microbiota transplantation inhibits multidrug-resistant gut pathogens: preliminary report performed in an immunocompromised host. Arch Immunol Ther Exp (Warsz). 2016;64(3):255–8.
Article
Google Scholar
Dinh A, Fessi H, Duran C, Batista R, Michelon H, Bouchand F, et al. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study. J Hosp Infect. 2018;99(4):481–6.
Article
CAS
PubMed
Google Scholar
Battipaglia G, Malard F, Rubio MT, Ruggeri A, Mamez AC, Brissot E, et al. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria. Haematologica. 2019;104(8):1682.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bilinski J, Lis K, Tomaszewska A, Grzesiowski P, Dzieciatkowski T, Tyszka M, et al. Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease-spectrum of responses and safety profile Results from a prospective, multicenter study. Am J Hematol. 2021;96(3):E88-91.
Article
PubMed
Google Scholar
Biliński J, Jasiński M, Tomaszewska A, Lis K, Kacprzyk P, Chmielewska L, et al. Fecal microbiota transplantation with ruxolitinib as a treatment modality for steroid-refractory/dependent acute, gastrointestinal graft-versus-host disease: A case series. Am J Hematol. 2021;96(12):E461–3.
Article
PubMed
Google Scholar
Zhao Y, Li X, Zhou Y, Gao J, Jiao Y, Zhu B, et al. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial. Front Immunol. 2021;17(12):2405.
Google Scholar
De Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut. 2021;70(1):92–105.
Article
PubMed
Google Scholar
Wang H, Lu Y, Yan Y, Tian S, Zheng D, Leng D, et al. Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired islets. Front Cell Infect Microbiol. 2020;9:455.
Article
PubMed
PubMed Central
Google Scholar
Paule A, Frezza D, Edeas M. Microbiota and phage therapy: future challenges in medicine. Med Sci. 2018;6(4):86.
CAS
Google Scholar
Hsu BB, Plant IN, Lyon L, Anastassacos FM, Way JC, Silver PA. In situ reprogramming of gut bacteria by oral delivery. Nat Commun. 2020;11(1):1–11.
Article
Google Scholar
Rasmussen TS, Koefoed AK, Jakobsen RR, Deng L, Castro-Mejia JL, Brunse A, et al. Bacteriophage-mediated manipulation of the gut microbiome – promises and presents limitations. FEMS Microbiol Rev. 2020;44(4):507–21.
Article
PubMed
Google Scholar
Descamps HC, Herrmann B, Wiredu D, Thaiss CA. The path toward using microbial metabolites as therapies. EBioMedicine. 2019;44:747–54.
Article
PubMed
PubMed Central
Google Scholar
Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, et al. Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: Inflammation mechanism, clinical prognostic, and potential as a therapeutic target. Front Pharmacol. 2019;10:1360.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ussher JR, Lopaschuk GD, Arduini A. Gut microbiota metabolism of l-carnitine and cardiovascular risk. Atherosclerosis. 2013;231(2):456–61.
Article
CAS
PubMed
Google Scholar
Videja M, Vilskersts R, Korzh S, Cirule H, Sevostjanovs E, Dambrova M, et al. Microbiota-derived metabolite trimethylamine n-oxide protects mitochondrial energy metabolism and cardiac functionality in a rat model of right ventricle heart failure. Front Cell Dev Biol. 2021;8:1808.
Article
Google Scholar
Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne). 2020;11:25.
Article
Google Scholar
Mizuno M, Noto D, Kaga N, Chiba A, Miyake S. The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS ONE. 2017;12(2): e0173032. https://doi.org/10.1371/journal.pone.0173032.
Article
CAS
PubMed
PubMed Central
Google Scholar
Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity. 2015;43(4):817–29.
Article
CAS
PubMed
Google Scholar
Chen T, Noto D, Hoshino Y, Mizuno M, Miyake S. Butyrate suppresses demyelination and enhances remyelination. J Neuroinflammation. 2019;16(1):1–13. https://doi.org/10.1186/s12974-019-1552-y.
Article
CAS
Google Scholar
Dalile B, Vervliet B, Bergonzelli G, Verbeke K, Van Oudenhove L. Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial. Neuropsychopharmacol. 2020;45(13):2257–66.
Article
CAS
Google Scholar
van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O’Sullivan O, et al. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain–gut axis alterations. J Physiol. 2018;596(20):4923–44. https://doi.org/10.1113/JP276431.
Article
CAS
PubMed
PubMed Central
Google Scholar
Campbell EA, Darst SA, Rice CM, Brady F. Metabolites with SARS-CoV-2 inhibitory activity identified from human microbiome commensals. Am Soc Microbiol. 2021;6(6):e00711-e721.
Google Scholar
Peng Y, Nie Y, Yu J, Wong CC. Microbial metabolites in colorectal cancer: basic and clinical implications. Metab. 2021;11(3):159.
CAS
Google Scholar
Le Leu RK, Winter JM, Christophersen CT, Young GP, Humphreys KJ, Hu Y, et al. Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial. Br J Nutr. 2015;114(2):220–30.
Article
PubMed
PubMed Central
Google Scholar
Park M, Kwon J, Shin HJ, Moon SM, Kim SB, Shin US, et al. Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient derived organoids. Int J Oncol. 2020;57(6):1307–18. https://doi.org/10.3892/ijo.2020.5132/abstract.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu S, Weiner HL. Control of the gut microbiome by fecal microRNA. Microb Cell. 2016;3(4):176.
Article
PubMed
PubMed Central
Google Scholar
Singh N, Shirdel EA, Waldron L, Zhang RH, Jurisica I, Comelli EM. The murine caecal microrna signature depends on the presence of the endogenous microbiota. Int J Biol Sci. 2012;8(2):171.
Article
CAS
PubMed
Google Scholar
Wen B, Tokar T, Taibi A, Chen J, Jurisica I, Comelli EM. Citrobacter rodentium alters the mouse colonic miRNome. Genes Immun. 2018;20(3):207–13.
Article
PubMed
Google Scholar
Taibi A, Singh N, Chen J, Arioli S, Guglielmetti S, Comelli EM. Time- and strain-specific downregulation of intestinal EPAS1 via miR-148a by Bifidobacterium bifidum. Mol Nutr Food Res. 2017;61(5):1600596. https://doi.org/10.1002/mnfr.201600596.
Article
CAS
Google Scholar
Axis M, Bosi A, Banfi D, Bistoletti M, Moretto P, Moro E, et al. Hyaluronan: A Neuroimmune Modulator in the cell. Cells. 2022;11(126):1–20.
Google Scholar
Huynh A, Priefer R. Hyaluronic acid applications in ophthalmology, rheumatology, and dermatology. Carbohydr Res. 2020;489:107950.
Article
CAS
PubMed
Google Scholar
Fuhlendorff BL, Schwach-Abdellaoui K, Longin F, Eenschooten C. New recombinant hyaluronic acid for eye care and ophthalmic drug delivery. Invest Ophthalmol Vis Sci. 2013;54(15):4327–4327.
Google Scholar
Hermans J, Bierma-Zeinstra SMA, Bos PK, Niesten DD, Verhaar JAN, Reijman M. The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: A randomised controlled trial. BMC Musculoskelet Disord. 2019;20(1):1–10. https://doi.org/10.1186/s12891-019-2546-8.
Article
Google Scholar
Longinotti C. The use of hyaluronic acid based dressings to treat burns: A review. Burn Trauma. 2014;2(4):162–8.
Article
Google Scholar
Petrey AC, de la Motte CA. Hyaluronan in inflammatory bowel disease: Cross-linking inflammation and coagulation. Matrix Biol. 2019;78–79:314–23.
Article
PubMed
Google Scholar
Vigetti D, Viola M, Karousou E, De Luca G, Passi A. Metabolic control of hyaluronan synthases. Matrix Biol. 2014;35:8–13.
Article
CAS
PubMed
Google Scholar
Okun E, Griffioen KJ, Mattson MP. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011;34(5):269–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feldman N, Rotter-Maskowitz A, Okun E. DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev. 2015;24:29–39.
Article
CAS
PubMed
Google Scholar
Lee Y, Sugihara K, Gillilland MG, Jon S, Kamada N, Moon JJ. Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis. Nat Mater. 2019;19(1):118–26.
Article
PubMed
PubMed Central
Google Scholar
Zheng L, Riehl TE, Stenson WF. Regulation of Colonic Epithelial Repair in Mice by Toll-Like Receptors and Hyaluronic Acid. Gastroenterology. 2009;137(6):2041–51.
Article
CAS
PubMed
Google Scholar
Filpa V, Bistoletti M, Caon I, Moro E, Grimaldi A, Moretto P, et al. Changes in hyaluronan deposition in the rat myenteric plexus after experimentally-induced colitis. Sci Rep. 2017;7(1):1–11.
Article
CAS
Google Scholar
Riaz Rajoka MS, Mehwish HM, Xiong Y, Song X, Hussain N, Zhu Q, et al. Gut microbiota targeted nanomedicine for cancer therapy: Challenges and future considerations. Trends Food Sci Technol. 2021;107:240–51.
Article
CAS
Google Scholar
Díaz-Garrido N, Badia J, Baldomà L. Microbiota-derived extracellular vesicles in interkingdom communication in the gut. J Extracell Vesicles. 2021;10(13): e12161. https://doi.org/10.1002/jev2.12161.
Article
PubMed
PubMed Central
Google Scholar
Han B, Lin CCJ, Hu G, Wang MC. ‘Inside Out’– a dialogue between mitochondria and bacteria. FEBS J. 2019;286(4):630–41. https://doi.org/10.1111/febs.14692.
Article
CAS
PubMed
Google Scholar
Saint-Georges-Chaumet Y, Edeas M. Microbiota-mitochondria inter-talk: consequence for microbiota-host interaction. FEMS Pathog Dis. 2016;12:9.
Google Scholar
Gu L, Ren F, Fang X, Yuan L, Liu G, Wang S. Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut microbiota composition, barrier function, and inflammatory status in an experimental colitis model. Front Med. 2021;10:898.
Google Scholar